Alnylam Pharmaceuticals Inc (HAM:DUL)
€ 202.6 +2.3 (+1.15%) Market Cap: 27.04 Bil Enterprise Value: 25.30 Bil PE Ratio: 43.91 PB Ratio: 23.33 GF Score: 70/100
Sorry the transcript is not found. Please try another one.